Lasa Supergenerics Limited (LASA)

26.58

INR
+1.03(+4.03%)
As of December 6, 2024 9:44:00 AM

Lasa Supergenerics Limited Share Price Information

24 hour Low and High

Low: 25.04999924
High: 26.06

All time High

93.92

Price Change 1h

+₹1.53 +6.11%

Price Change 1d

+₹1.53 +6.11%

Price Change 1w

+₹0.83 +3.22%

Lasa Supergenerics Limited Market Information

Exchange

NSE

Market Cap

131.05 Cr

About Lasa Supergenerics Limited Share

Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products in India. It offers API products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, ricobendazole, oxfendazole, closantel base, closantel sodium dihydrate BP, nitroxynil, rafoxanide, oxyclozanide, ornidazole, and halquinol, as well as 2,6-diiodo-4-nitrophenol; and other API products. The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use, such as potassium iodide. In addition, it exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Ratnagiri, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

77

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Lasa Supergenerics Q1 Results Live: Loss Falls by 44.81% YoY | Company Business News
  • Lasa Supergenerics' Stock Hits 52-Week High, Outperforms Sensex in Past Year
  • Lasa Supergenerics lists at Rs 140.20 on NSE; Omkar Speciality drops 5%
  • NCLT dismisses insolvency petition against Lasa Supergenerics, ET LegalWorld
  • Lasa Supergenerics acquires Harishree Aromatics

FAQs

Lasa Supergenerics Limited (LASA)

26.58

INR
+1.03(+4.03%)
As of December 6, 2024 9:44:00 AM

Lasa Supergenerics Limited Share Price Information

24 hour Low and High

Low: 25.04999924
High: 26.06

All time High

93.92

Price Change 1h

+₹1.53 +6.11%

Price Change 1d

+₹1.53 +6.11%

Price Change 1w

+₹0.83 +3.22%

Lasa Supergenerics Limited Market Information

Exchange

NSE

Market Cap

131.05 Cr

About Lasa Supergenerics Limited Share

Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products in India. It offers API products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, ricobendazole, oxfendazole, closantel base, closantel sodium dihydrate BP, nitroxynil, rafoxanide, oxyclozanide, ornidazole, and halquinol, as well as 2,6-diiodo-4-nitrophenol; and other API products. The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use, such as potassium iodide. In addition, it exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Ratnagiri, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

77

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Lasa Supergenerics Q1 Results Live: Loss Falls by 44.81% YoY | Company Business News
  • Lasa Supergenerics' Stock Hits 52-Week High, Outperforms Sensex in Past Year
  • Lasa Supergenerics lists at Rs 140.20 on NSE; Omkar Speciality drops 5%
  • NCLT dismisses insolvency petition against Lasa Supergenerics, ET LegalWorld
  • Lasa Supergenerics acquires Harishree Aromatics

FAQs